CAS NO: | 13602-53-4 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Angiotensin III, human, mouse is a heptapeptide, acts as an endogenousangiotensin type 2 receptor (AT2R)agonist, withIC50s of 0.648 nM and 21.1 nM for AT2R and AT1R, respectively. | ||||||||||||||||
IC50& Target | IC50: 0.648 nM (AT2R), 21.1 nM (AT1R)[1] | ||||||||||||||||
体外研究 (In Vitro) | Angiotensin III, human, mouse is a heptapeptide, acts as an endogenous angiotensin type 2 receptor (AT2R) agonist, with IC50s of 0.648 nM and 21.1 nM for AT2R and AT1R, respectively[1]. | ||||||||||||||||
体内研究 (In Vivo) | Angiotensin III (7, 14 and 28 nmol/kg/min) increases urine sodium excretion (UNaV), fractional excretion of sodium (FENa), and fractional excretion of lithium (FELi) in SD rat[2]. In RAS (renin-angiotensin system), Angiotensin III increases sympathetic nerve activity and vasopressin release and decreases the baroreflex leading to higher blood pressure in rats[3]. | ||||||||||||||||
分子量 | 931.09 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C46H66N12O9 | ||||||||||||||||
CAS 号 | 13602-53-4 | ||||||||||||||||
Sequence | Arg-Val-Tyr-Ile-His-Pro-Phe | ||||||||||||||||
Sequence Shortening | RVYIHPF | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 100 mg/mL(107.40 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |